Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy
- PMID: 16371020
- DOI: 10.1111/j.1365-2141.2005.05843.x
Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy
Abstract
Cytotoxic T lymphocyte (CTL) lines specific for allogeneic antigens were generated by in vitro stimulation of donor-derived peripheral blood mononuclear cells obtained from patients who received human leucocyte antigen (HLA)-matched allogeneic haematopoietic stem cell transplantation (HSCT). One of the allogeneic antigen-specific CD4+ CTL lines, CTL-A, generated from a patient with T cell acute lymphoblastic leukaemia, recognised HLA-DPB1*0501-positive Epstein-Barr virus-immortalised human B cell line (EBV-B cells), phytohaemagglutinin blasts and leukaemia cells, but not interferon-gamma (IFN-gamma) treated HLA-DPB1*0501-positive fibroblasts, indicating that this CD4+ T-cell line recognised a minor histocompatibility antigen (mHa) that is preferentially expressed in haematopoietic cells in an HLA-DPB1*0501-restricted manner. The other CD4+ CTL line, CTL-B, generated from a patient with chronic myeloid leukaemia, recognised mismatched HLA-DQB1*0303 on EBV-B cells and phytohaemagglutinin (PHA) blasts. Interestingly, this CTL line did not recognise IFN-gamma-treated recipient's skin fibroblasts, as HLA-DQ was merely upregulated even after IFN-gamma stimulation in non-haematopoietic cells including fibroblasts, endothelial cells and hepatocytes. These results suggest that these CD4 positive CTLs, specific for mismatch HLA-DQ and mHa that are preferentially expressed on haematopoietic cells, may play an important role in induction of selective graft-versus-leukaemia effect without development of graft-versus-host disease after allogeneic HSCT.
Similar articles
-
A class II-restricted cytotoxic T-cell clone recognizes a human minor histocompatibility antigen with a restricted tissue distribution.Br J Haematol. 2005 Jan;128(1):73-81. doi: 10.1111/j.1365-2141.2004.05283.x. Br J Haematol. 2005. PMID: 15606552
-
Mismatched human leukocyte antigen class II-restricted CD8⁺ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation.Cancer Sci. 2011 Jul;102(7):1281-6. doi: 10.1111/j.1349-7006.2011.01949.x. Epub 2011 May 9. Cancer Sci. 2011. PMID: 21466613
-
Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.Transplantation. 2008 Nov 27;86(10):1427-35. doi: 10.1097/TP.0b013e31818810d6. Transplantation. 2008. PMID: 19034014
-
The allogeneic graft-versus-cancer effect.Br J Haematol. 2009 Dec;147(5):614-33. doi: 10.1111/j.1365-2141.2009.07886.x. Epub 2009 Sep 4. Br J Haematol. 2009. PMID: 19735262 Review.
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
Cited by
-
Allo-reactive T cells for the treatment of hematological malignancies.Mol Oncol. 2015 Dec;9(10):1894-903. doi: 10.1016/j.molonc.2015.10.014. Epub 2015 Oct 24. Mol Oncol. 2015. PMID: 26578450 Free PMC article. Review.
-
HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation.Leukemia. 2017 Feb;31(2):434-445. doi: 10.1038/leu.2016.210. Epub 2016 Aug 1. Leukemia. 2017. PMID: 27479183
-
IL-12 immunotherapy of murine leukaemia: comparison of systemic versus gene modified cell therapy.J Cell Mol Med. 2009 Aug;13(8B):1962-1976. doi: 10.1111/j.1582-4934.2008.00412.x. J Cell Mol Med. 2009. PMID: 18624776 Free PMC article.
-
Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia.Blood. 2007 Sep 15;110(6):1924-32. doi: 10.1182/blood-2007-03-076844. Epub 2007 May 15. Blood. 2007. PMID: 17505014 Free PMC article.
-
Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation.Best Pract Res Clin Haematol. 2008 Sep;21(3):437-53. doi: 10.1016/j.beha.2008.07.004. Best Pract Res Clin Haematol. 2008. PMID: 18790448 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials